Xeris Biopharma Holdings, Inc. (XERS)

Market Closed

17 Jul, 20:00

NASDAQ (NGS)

$

8. 80

+0.11

+1.2658%

1.43B Market Cap

- P/E Ratio

- Div Yield

1.61M Volume

-0.38 Eps

$ 8.69

Previous Close

Investors:

Add Transaction

Day Range

8.49 9

Year Range

4.87 10.08

Want to track XERS and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

Xeris Biopharma Holdings, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
MA Marie-Andree Alain Federation des caisses Desjardins du Quebec	1,500	$8,700	$13,200	$4,500	51.72%
Zachary Canonico DIADEMA PARTNERS LP	132,746	$1.05M	$1.17M	$115,398.8	10.96%
Mark Schafer Police & Firemen's Retirement System of New Jersey	40,738	$184,191.14	$358,494.4	$174,303.26	94.63%
William Staveacre Aster Capital Management (DIFC) Ltd.	687	$3,984.6	$6,045.6	$2,061	51.72%
Kirsten Syverson Integrated Quantitative Investments LLC	66,170	$519,434	$582,296	$62,862	12.1%
Jacksonville Wealth Management LLC Jacksonville Wealth Management LLC	17,000	$138,380	$149,600	$11,220	8.11%
BM Berkeley Meredith Hughes Financial Services LLC	4	$23	$35.62	$12.62	54.87%
Yuen Man Lee Persistent Asset Partners Ltd.	35,661	$282,042.61	$316,491.37	$34,448.76	12.21%
TG Timothy Golas Spurstone Advisory Services LLC	200	$678	$1,781	$1,103	162.68%
GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.	3,710	$15,104.29	$32,773.03	$17,668.74	116.98%
JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH	14,192	$115,221.51	$125,367.87	$10,146.36	8.81%

1
2

Blog Affiliate Program About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.